Merck KGaA and Jerini Announce Collaboration to Develop Small Molecule Cancer Drugs(29 Jan 2004) Merck KGaA and Jerini AG announced a collaboration agreement to jointly develop small molecule inhibitors against an undisclosed target for oncology. Prior to the agreement, Jerini identified novel proprietary small molecule lead series by applying ...
Top